PubRank

Stefano Toldo

Author PubWeight™ 24.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting interleukin-1 in heart disease. Circulation 2013 2.52
2 The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A 2011 1.81
3 Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation 2009 1.40
4 Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J Heart Fail 2010 1.19
5 Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med 2011 1.19
6 Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS One 2012 1.08
7 Letter by Mezzaroma, et al regarding article, "NLRP3 inflammasome as a therapeutic target in myocardial infarction". Int Heart J 2014 1.08
8 Role of NLRP3 (cryopyrin) in acute myocardial infarction. Cardiovasc Res 2013 1.03
9 Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol 2010 0.94
10 Pharmacologic inhibition of myeloid differentiation factor 88 (MyD88) prevents left ventricular dilation and hypertrophy after experimental acute myocardial infarction in the mouse. J Cardiovasc Pharmacol 2010 0.91
11 Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. PLoS One 2011 0.91
12 The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. Mol Cancer Res 2010 0.90
13 Interleukin-1β induces a reversible cardiomyopathy in the mouse. Inflamm Res 2013 0.89
14 Anakinra in experimental acute myocardial infarction--does dosage or duration of treatment matter? Cardiovasc Drugs Ther 2008 0.88
15 Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin. ACS Chem Neurosci 2014 0.87
16 Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am J Pathol 2012 0.86
17 Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice. J Cardiovasc Pharmacol 2010 0.85
18 A mouse model of radiation-induced cardiomyopathy. Int J Cardiol 2012 0.85
19 Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse. J Cardiovasc Pharmacol 2015 0.84
20 Right ventricular systolic dysfunction in patients with reperfused ST-segment elevation acute myocardial infarction. Int J Cardiol 2011 0.80
21 Identification of protein-protein interactions of human HtrA1. Front Biosci (Elite Ed) 2011 0.79
22 Apoptosis in patients with acute myocarditis. Am J Cardiol 2009 0.76
23 Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha. J Cardiovasc Pharmacol 2017 0.75
24 Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction. Circ Res 2010 0.75
25 A Preclinical Translational Study Of The Cardioprotective Effects Of Plasma Derived Alpha-1 Anti-Trypsin In Acute Myocardial Infarction. J Cardiovasc Pharmacol 2017 0.75
26 Determination of Optimal Coronary Flow for the Preservation of "Donation after Circulatory Death" in Murine Heart Model. ASAIO J 2017 0.75